Articles about Kaiser-Permanente

Allen Institute will host $40.5M brain research center to map the effects of Alzheimer’s disease

A $40.5 million collaborative research center headquartered at Seattle’s Allen Institute aims to create high-resolution maps of brains ravaged by… Read More

Positive news about Seattle-tested coronavirus vaccine sends stock market sharply higher

Massachusetts-based Moderna’s share price — and the stock market as a whole — were lifted today by the company’s encouraging… Read More

After good results in Seattle, COVID-19 vaccine will face key trials this summer, Moderna CEO says

The coronavirus vaccine trial that started out in Seattle is progressing well enough to get onto Food and Drug Administration’s… Read More

Seattle techies get the first shots in Kaiser Permanente’s coronavirus vaccine trial

Seattle’s tech community is well-represented in the first group of participants to get their shots in the first U.S. clinical… Read More

Tech Moves: Kaiser Permanente names head of research in Washington state; Offerpad lures former Zillow exec; and more

— Kaiser Permanente landed Dr. Rita Mangione-Smith to lead its Washington Health Research Institute. Mangione-Smith is a pediatrician by training… Read More

High-tech healthcare: Behind-the-scenes inside Kaiser Permanente’s automated lab and pharmacy

Automation technology is helping fill prescription orders and diagnose patient specimens much faster and safer than ever before. As part… Read More

Geek of the Week: IT veteran Joe Hueffed might have the most iconic Seattle resume ever

Joe Hueffed grew up in Seattle’s Capitol Hill neighborhood and later graduated from Seattle University. From there, the IT veteran’s… Read More